- Category
- Micro (2021-22)
- Udyam number
- UDYAM-UP-50-0031836

Ellevanta Pharmaceutical Private Limited
About Ellevanta Pharmaceutical Private Limited
Data last updated:
Ellevanta Pharmaceutical Private Limited is a private limited company based in Lucknow, Uttar Pradesh, India. It operates in the preventive health supplements segment of the healthcare sector. It was incorporated on 01 September 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U24290UP2021PTC151483. Its GSTIN is 09AAGCE6280R1ZT (Uttar Pradesh).
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹1.2 Lakh. It is led by directors including Sudha Pandey and Mandeep Kaur.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 570/469 Pakari Alambagh, Lucknow, Uttar Pradesh, India – 226005.
As per the financials filed for FY 2025, the company reported a revenue of ₹41.52 Lakh, a growth of 25% compared to the previous year. For the same year it recorded a net profit of ₹6,298 (net margin 0.2%) and EBITDA of ₹8,508 (EBITDA margin 0.2%). Revenue has grown at a compounded annual rate (CAGR) of 120% over three years.
Ellevanta Pharmaceutical Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-50-0031836).
Company details
Recognitions & Rankings of Ellevanta Pharmaceutical
Contact details
Ellevanta Pharmaceutical Private Limited's registered office is in Lucknow, Uttar Pradesh. Its e-mail address is in the company report.
- Email
- Registered Address570/469 Pakari Alambagh, Lucknow, Uttar Pradesh, India – 226005
- IndustryHealthcare, Preventive Health Supplements
To see the full contact details of Ellevanta Pharmaceutical Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Ellevanta Pharmaceutical is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Ellevanta Pharmaceutical Private Limited, buy the company report.
Financials of Ellevanta Pharmaceutical Private Limited
FY 2025 filings availableEllevanta Pharmaceutical Private Limited reported revenue of ₹41.52 Lakh (up 25% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 120% over three years, including 25% growth in the latest year. EBITDA fell 83% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹8,508 | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹6,298 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 0.2% | |||
| Net Profit Margin | 0.2% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Ellevanta Pharmaceutical Private Limited, buy the company report.
Board of directors of Ellevanta Pharmaceutical Private Limited
Ellevanta Pharmaceutical has 4 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sudha Pandey | Director | 01 Sep 2021 | 5 Years 2 Months | Current |
| Mandeep Kaur | Director | 01 Sep 2021 | 5 Years 2 Months | Current |
| Nitika Pandey | Director | 01 Sep 2021 | 5 Years 2 Months | Current |
| Babita Pandey | Director | 06 Jan 2022 | 4 Years 10 Months | Current |
Legal cases
No court or tribunal cases involving Ellevanta Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ellevanta Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Ellevanta Pharmaceutical has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAGCE6280R1ZT | Uttar Pradesh | Active | 25 Nov 2021 |
To see the full GST registrations and return filing status of Ellevanta Pharmaceutical Private Limited, buy the company report.
Recent activity
Ellevanta Pharmaceutical Private Limited has 4 board changes on record since 2021: 4 appointments. The latest: Babita Pandey was appointed as Director on 06 Jan 2022.
Frequently asked questions
Ellevanta Pharmaceutical is an active private limited company based in Lucknow, Uttar Pradesh, India. The company works in preventive health supplements, within the healthcare industry. It was incorporated on 01 September 2021 (5+ years old) and is registered under CIN U24290UP2021PTC151483.
Ellevanta Pharmaceutical has 4 current directors:
- Sudha Pandey - Director
- Mandeep Kaur - Director
- Nitika Pandey - Director
- Babita Pandey - Director
The latest financial statements of Ellevanta Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The GSTIN of Ellevanta Pharmaceutical is 09AAGCE6280R1ZT, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Ellevanta Pharmaceutical is U24290UP2021PTC151483. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ellevanta Pharmaceutical was incorporated on 01 September 2021, making it 5+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
Babita Pandey was appointed as Director on 06 Jan 2022. Mandeep Kaur was appointed as Director on 01 Sep 2021. Nitika Pandey was appointed as Director on 01 Sep 2021. Ellevanta Pharmaceutical has 4 board changes on record in total.
Yes, Ellevanta Pharmaceutical is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-50-0031836).
The registered office of Ellevanta Pharmaceutical is at 570469 Pakari Alambagh, Lucknow, Uttar Pradesh, India – 226005.
Ellevanta Pharmaceutical operates in the healthcare industry, in the preventive health supplements segment.

